BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36204)

  • 1. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
    Gale K; Guidotti A; Costa E
    Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J; Lindqvist E; Young D; Cowburn R
    Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
    Minneman KP; Quik M; Emson PC
    Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic localization of substance P degradative enzymes(s) in rat substantia nigra.
    Quik M; Emson PC
    Neurosci Lett; 1979 Dec; 15(2-3):217-22. PubMed ID: 93730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum.
    Spano PF; Trabucchi M; Di Chiara G
    Science; 1977 Jun; 196(4296):1343-5. PubMed ID: 17159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 15. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 17. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine metabolism, spiperone binding and adenylate cyclase activity in the adult rat hippocampus after ingrowth of dopaminergic neurones from embryonic implants.
    Bischoff S; Scatton B; Korf J
    Brain Res; 1979 Dec; 179(1):77-84. PubMed ID: 509234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.